Evidence map›Paper›PMID 32202514›Full record

ArticleThe Journal of clinical investigation2020

Fetal alcohol spectrum disorder predisposes to metabolic abnormalities in adulthood.

Olivia Weeks, Gabriel D Bossé, Isaac M Oderberg, Sebastian Akle, Yariv Houvras, Paul J Wrighton, Kyle LaBella, Isabelle Iversen, Sahar Tavakoli, Isaac Adatto and 8 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Growth hormone therapy in a patient with short stature due to fetal alcohol syndrome: seven-year follow-up.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Olivia WeeksDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Gabriel D BosséDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA.
Isaac M OderbergDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Sebastian AkleDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Yariv HouvrasDepartment of Surgery and.
Paul J WrightonDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kyle LaBellaDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Isabelle IversenDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Sahar TavakoliDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA.
Isaac AdattoDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA.
Arkadi SchwartzDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Daan KloostermanDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Allison TsomidesDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Michael E CharnessVeterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA.
Randall T PetersonDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA.
Matthew L SteinhauserDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Pouneh K FazeliNeuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Wolfram GoesslingDivision of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Brigham and Women's Hospital · USHarvard University · USBroad Institute · USUniversity of Utah · USBoston University · USCornell University · US

Funding

A Community Zebrafish Resource for Modeling GWAS BiologyR24OD017870 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM, MACRAE, CALUM A. · 2014 to 2021
$6.3M
Estrogen Regulation of Hepatic GrowthR01DK090311 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2011 to 2020
$4.9M
ALCOHOL AND CELL ADHESIONR37AA012974 · NIAAA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI CHARNESS, MICHAEL EDWARD · 2002 to 2010
$4.3M
Metabolic Regulation of Liver GrowthR01DK105198 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2016 to 2020
$2.7M
ALCOHOL AND CELL ADHESIONR01AA012974 · NIAAA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI CHARNESS, MICHAEL EDWARD · 2001 to 2016
$2.4M
Identification of novel regulators of liver regeneration using single-cell approachesF32AA027135 · NIAAA · BRIGHAM AND WOMEN'S HOSPITAL · PI ODERBERG, ISAAC MAX · 2019 to 2021
$200k
The role of mechanical signaling in alcoholic liver disease and hepatocellular carcinomaF32AA025271 · NIAAA · BRIGHAM AND WOMEN'S HOSPITAL · PI WRIGHTON, PAUL J. · 2016 to 2018
$174k
Chronic disease risk and genetic risk factors in fetal alcohol spectrum disorderF31AA025254 · NIAAA · HARVARD MEDICAL SCHOOL · PI WEEKS, OLIVIA · 2017 to 2018
$64k
BLRD VA I01 BX002374NIAAA NIH HHS F31 AA025254NIAAA NIH HHS F32 AA025271NIAAA NIH HHS F32 AA027135NIAAA NIH HHS R01 AA012974NIAAA NIH HHS R37 AA012974NIDDK NIH HHS R01 DK090311NIDDK NIH HHS R01 DK105198NIH HHS R24 OD017870
6 · The paper itself

Abstract

Prenatal alcohol exposure (PAE) affects at least 10% of newborns globally and leads to the development of fetal alcohol spectrum disorders (FASDs). Despite its high incidence, there is no consensus on the implications of PAE on metabolic disease risk in adults. Here, we describe a cohort of adults with FASDs that had an increased incidence of metabolic abnormalities, including type 2 diabetes, low HDL, high triglycerides, and female-specific overweight and obesity. Using a zebrafish model for PAE, we performed population studies to elucidate the metabolic disease seen in the clinical cohort. Embryonic alcohol exposure (EAE) in male zebrafish increased the propensity for diet-induced obesity and fasting hyperglycemia in adulthood. We identified several consequences of EAE that may contribute to these phenotypes, including a reduction in adult locomotor activity, alterations in visceral adipose tissue and hepatic development, and persistent diet-responsive transcriptional changes. Taken together, our findings define metabolic vulnerabilities due to EAE and provide evidence that behavioral changes and primary organ dysfunction contribute to resultant metabolic abnormalities.

Indexed as

Diabetes Mellitus, Type 2Fetal Alcohol Spectrum DisordersObesityPrenatal Exposure Delayed EffectsAdultAnimalsFemaleHumansInfant, NewbornIntra-Abdominal FatLiverMaleMiceMice, TransgenicPregnancyRegistriesDevelopmentEmbryonic developmentMetabolismObesity

Identifiers

PMID32202514
PMCPMC7190939
OpenAlexW3012764207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.